Workboat Indexes

Markets:

Overview

News

Currencies

International

Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

287.73 +8.48 (+3.04%)

Streaming Delayed Price Updated: 3:13 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

April 15, 2025

From Bio-Rad Laboratories, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 10, 2025

Via Benzinga

Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday? ↗

February 14, 2025

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.

Via Benzinga

Topics Stocks

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

The Analyst Verdict: Bio-Rad Laboratories In The Eyes Of 4 Experts ↗

January 14, 2025

Via Benzinga

Expert Ratings For Bio-Rad Laboratories ↗

October 01, 2024

Via Benzinga

Earnings Scheduled For May 1, 2025 ↗

May 01, 2025

Via Benzinga

A Preview Of Bio-Rad Laboratories's Earnings ↗

April 30, 2025

Via Benzinga

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

April 23, 2025

Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology

From Biodesix, Inc.

Via GlobeNewswire

Triple-Witch Says, “Remember Me?” ↗

September 20, 2024

Via Talk Markets

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

February 13, 2025

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

February 13, 2025

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

January 27, 2025

From Bio-Rad Laboratories, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 21, 2025

Via Benzinga

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

January 08, 2025

From Geneoscopy, Inc.

Via Business Wire

Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

January 02, 2025

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

November 21, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

October 31, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Reports Third-Quarter 2024 Financial Results

October 30, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

October 14, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

S&P 500 Shake-Up: New Entrants Driving Market Momentum

September 24, 2024

The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors.

Via MarketBeat

Topics Artificial Intelligence Stocks

Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward. ↗

September 13, 2024

History says Palantir stock could soar after its inclusion in the S&P 500.

Via The Motley Fool

Topics Stocks

Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next? ↗

September 09, 2024

Palantir (PLTR) stock surges due to inclusion in S&P 500 on Sept. 23 and new enterprise deal with BP. Technicals also show bullish trend.

Via Benzinga

Topics Artificial Intelligence Stocks

Palantir, Dell Will Join The S&P 500. The AI Stocks Are Jumping. ↗

September 06, 2024

Palantir, Dell Technologies and Erie Indemnity will join the S&P 500 on Sept. 23. All three stocks jumped late Friday.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference

August 22, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

August 20, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Reports Second-Quarter 2024 Financial Results

August 01, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

July 17, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months ↗

June 30, 2024

The market's resilient run has made traders cautious of a potential correction, but analysts remain optimistic about its trajectory.

Via Benzinga

Topics Stocks

OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics

June 05, 2024

Via AB Newswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Workboat Indexes

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

Zinus Power to supply shore power systems for Connecticut pier project

Bedrock names Matthew Tirman CEO

Avoid potential pitfalls in train-the-trainer programs

Blessey Marine christens its first Tier 4 towboat